Nasal delivery as a strategy for the prevention and treatment of COVID-19

F Sonvico, G Colombo, E Quarta… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The upper respiratory tract is a major route of infection for COVID-19 and other
respiratory diseases. Thus, it appears logical to exploit the nose as administration site to …

The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19

JY Wu, MY Liu, MC Lee, KC Hung… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study investigated the outcomes of underweight patients with COVID-19 and
the effectiveness of antiviral agents in this population. Methods A retrospective cohort study …

Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection

JY Wu, MY Liu, WH Hsu, YW Tsai, TH Liu… - European Journal of …, 2024 - Springer
Objectives This study aimed to investigate the association between vitamin D deficiency
(VDD) and post-acute outcomes of severe acute respiratory syndrome coronavirus 2 (SARS …

Nutritional deficiency anemia and post‐acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six‐month retrospective cohort …

JY Wu, MY Liu, KC Hung, WH Hsu… - Journal of Medical …, 2023 - Wiley Online Library
The effect of anemia on the post‐acute outcome of patients with severe acute respiratory
syndrome coronavirus 2 infection was unclear. This study aimed to investigate the potential …

Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …

BW Shiau, WH Hsu, YW Tsai, JY Wu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

CK Hsu, WH Hsu, BW Shiau, YW Tsai… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study investigated the association between nirmatrelvir plus ritonavir (NMV-
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …

[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer

WH Hsu, BW Shiau, YW Tsai, JY Wu, PY Huang… - Journal of Infection and …, 2024 - Elsevier
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …

Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐and long‐term outcome in high‐risk children with COVID‐19

JY Wu, CC Chen, MY Liu, WH Hsu… - Journal of Medical …, 2024 - Wiley Online Library
This study investigated the clinical effectiveness of nirmatrelvir plus ritonavir (NMV‐r) on
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …

Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease

CC Chen, CY Huang, JY Wu, MY Liu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study examined the effectiveness of nirmatrelvir plus ritonavir (NMV-r) and
molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients …

[HTML][HTML] Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity …

CY Lee, YC Liang, WH Hsu, YW Tsai, TH Liu… - Life, 2024 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like …